1Hardt PD,Ewald N.Tumor M2pyruvate kinase:a tumor marker and its clinical application in gastrointestinal malignancy[].Expert Review of Molecular Diagnostics.2008
2Miyagi T,Wada T,Yamaguchi K,et al.Human sialidase as a cancer marker[].Proteomics.2008
3Sturgeon CM,Duffy MJ,Stenman UH,et al.National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular,prostate,colorectal,breast,and ovarian cancers[].Clinical Chemistry.2008
4Gupta AK,Brenner DE,Turgeon DK.Early detection of colon cancer:new tests on the horizon[].Mol Diagn Ther.2008
5Cordero OJ,De Chiara L,Lemos-González Y,et al.Howthe measurements of a fewserummarkers can be combined to enhance their clinical values in the management of cancer[].Anticancer Research.2008
6Zucchelli GC,Pilo A,Chiesa MR,et al.Minimizing between-kit variability in immunoassay for carcinoembryonic antigen by use of a common standard[].Clinical Chemistry.1986
7Slev PR,La′ulu SL,Roberts WL.Intermethod differences in results for total PSA,free PSA,and percentage of free PSA[].American Journal of Clinical Pathology.2008
8B rmer OP.Standardization,specificity,and diagnostic sensitivity of four immunoassays for carcinoembryonic antigen[].Clinical Chemistry.1991
9Stamey TA. Urology . 1995
10Stephan C.Prostate cancer:WHO standardization of PSA tests:clinical consequences[].Nat Rev Urol.2009
